Eastell, Richard <br/><br/>
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  05 2019 
 - 1595-1622 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2019-00221  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Accidental Falls--prevention & control<br/>Bone Density Conservation Agents--therapeutic use<br/>Calcitonin--therapeutic use<br/>Calcium--therapeutic use<br/>Clinical Decision-Making<br/>Denosumab--therapeutic use<br/>Diphosphonates--therapeutic use<br/>Estrogen Receptor Modulators--therapeutic use<br/>Estrogen Replacement Therapy<br/>Female<br/>Humans<br/>Norpregnenes--therapeutic use<br/>Osteoporosis, Postmenopausal--diagnostic imaging<br/>Osteoporotic Fractures--prevention & control<br/>Parathyroid Hormone-Related Protein--therapeutic use<br/>Patient Preference<br/>Raloxifene Hydrochloride--therapeutic use<br/>Risk Assessment<br/>Risk Reduction Behavior<br/>Selective Estrogen Receptor Modulators--therapeutic use<br/>Teriparatide--therapeutic use<br/>Vitamin D--therapeutic use